Formulation technologies that form fluid suspensions |
XerijectTM (Xeris Pharmaceuticals, Chicago, IL, USA) |
Uses specialized particle engineering techniques to create paste formulations |
[40] |
ElektrojectTM (Elektrofi, Boston, MA, USA) |
Uses a gentle atomization/desiccation procedure to create microparticles with high protein loading with improved long term physical and chemical stability |
[41] |
MicroglassificationTM (Lindy Biosciences, Durham, NC, USA) |
Enables the dehydration of proteins or other biologics into stable, spherical microbeads |
[42] |
Crystalomics® (Althea/Ajinomoto Bio-Pharma, San Diego, CA, USA) |
Creates crystal suspensions |
[43] |
Formulation technologies that minimize intermolecular interactions in solution to reduce viscosity of high-concentration formulations |
ArestatTM (Arecor, Little Chesterford, UK) |
Uses buffering agents and formulation excipients to improve protein/peptide stability in aqueous solutions |
[44] |
BioChaperone® (Adocia, Lyon, France) |
Forms a molecular complex with therapeutic proteins of interest that improves their solubility and stability |
[45] |
EXCELSETM (ExcelseBio, Thousand Oaks, CA, USA) |
Uses a customized amino acid blend that coats key molecular regions responsible for the increase in viscosity, thereby preventing clumping and protein instability |
[46] |
Devices that allow for SC injection of high viscosity formulations |
Safelia® autoinjector (Nemera, La Verpillière, France) |
Uses a cam system to manage the increased spring force to deliver 1 or 2.25 mL fluids of up to 1000 cP viscosity |
[47] |
Autoject® Visco autoinjector (Owen Mumford, Oxfordshire, UK) |
Uses a velocity regulator to minimize shock and noise |
[48,49] |
YpsoMate 2.25 Pro autoinjector (Ypsomed, Burgdorf, Switzerland) |
Uses a drive system with constant force to deliver up to 2.25 mL of up to 50 cP viscosity |
[50] |
Rotaject® autoinjector (SHL Group, Zug, Switzerland) |
Uses torsion springs and regulators to control the application of force over time to deliver 1 or 2.25 mL fluids of up to several 100 cP viscosity |
[51] |
Vapoursoft® powered autoinjectors (Bespak, King’s Lynn, UK) |
Uses the expansion of a compressed gas to replace spring force and minimize the impact on primary containers to deliver 1 or 2.25 mL |
[52] |
AutoTouch™ autoinjector (Amgen, Thousand Oaks, CA, USA) |
Uses electromechanical motors to finely control the application of force over time and tailor injection rate to patient preference |
[53,54] |
ArQ®-Bios (Oval Medical Technologies, Cambridge, UK) |
Uses cyclo-olefin co-polymer containers that are strong enough to withstand the stresses of delivering 1 mL of a 1000 cP fluid in 5 seconds |
[55] |